Table 1.

Patients, disease, and transplantation characteristics

Characteristicsn = 107
Recipient  
 Median age, y (range) 35 (3-56)  
 Median weight, kg (range) 65 (15-126)  
 Male (%) 67 (63)  
 Children, 15 y or younger (%) 17 (16)  
 Positive CMV serology (%) 46 (43)  
Underlying diagnosis   
 Chronic leukemia (%) 68 (64)  
 Acute leukemia (%) 39 (36)  
Disease stage   
 Early (%) 82 (77)  
 Intermediate (%) 20 (19)  
 Advanced (%) 5 (5) 
Donor   
 Median age, y (range) 34 (2-65)  
 Male (%) 56 (52)  
 Female donor to male recipient (%) 31 (29) 
 Sex match (%) 56 (52)  
 ABO match (%) 72 (67) 
 ABO major incompatibility (%) 17 (16)  
 Positive CMV serology (%) 56 (55) 
Transplantation   
 Conditioning  
  TBI + CY ± others (%) 32 (30)  
  Bu + CY (%) 58 (54)  
 GVHD prophylaxis  
  CSA + MTX (%) 94 (88)  
  CSA + MTX + other (%) 6 (6)  
  CSA ± corticosteroids (%) 7 (6) 
Graft composition   
 Median NC, 108/kg (range) 2.4 (0.2-8.1)  
 Median CD34, 106/kg (range) n = 83 3.6 (0.07-17.9) 
Characteristicsn = 107
Recipient  
 Median age, y (range) 35 (3-56)  
 Median weight, kg (range) 65 (15-126)  
 Male (%) 67 (63)  
 Children, 15 y or younger (%) 17 (16)  
 Positive CMV serology (%) 46 (43)  
Underlying diagnosis   
 Chronic leukemia (%) 68 (64)  
 Acute leukemia (%) 39 (36)  
Disease stage   
 Early (%) 82 (77)  
 Intermediate (%) 20 (19)  
 Advanced (%) 5 (5) 
Donor   
 Median age, y (range) 34 (2-65)  
 Male (%) 56 (52)  
 Female donor to male recipient (%) 31 (29) 
 Sex match (%) 56 (52)  
 ABO match (%) 72 (67) 
 ABO major incompatibility (%) 17 (16)  
 Positive CMV serology (%) 56 (55) 
Transplantation   
 Conditioning  
  TBI + CY ± others (%) 32 (30)  
  Bu + CY (%) 58 (54)  
 GVHD prophylaxis  
  CSA + MTX (%) 94 (88)  
  CSA + MTX + other (%) 6 (6)  
  CSA ± corticosteroids (%) 7 (6) 
Graft composition   
 Median NC, 108/kg (range) 2.4 (0.2-8.1)  
 Median CD34, 106/kg (range) n = 83 3.6 (0.07-17.9) 

Disease stage is based on International Bone Marrow Transplant Registry classification.

NC indicates nucleated cells.